McKesson Appoints Brian Tyler to Executive Vice President of Corporate Strategy and Business Development

Tyler Will Remain President of McKesson’s U.S. Pharmaceutical Business until a Successor is Named

SAN FRANCISCO--()--McKesson Corporation (NYSE: MCK) today announced that Brian Tyler has been appointed executive vice president of corporate strategy and business development, effective immediately. Tyler will report to chairman and CEO John Hammergren and will become a member of the executive committee. Tyler succeeds Marc Owen, who joined McKesson Specialty Health as president earlier this year.

This appointment fills a crucial role for the company, as Tyler will guide strategy development with McKesson’s business unit leaders, help foster innovation and source acquisitions that add new growth opportunities for the company. Tyler will remain president of McKesson’s U.S. Pharmaceutical business while the company searches for his successor.

“With his deep understanding of the healthcare industry and relationships in the manufacturer, physician, hospital, and pharmacy markets, Brian Tyler is exceptionally qualified to lead our corporate strategy and business development team,” said John Hammergren, chairman and CEO, McKesson Corporation. “His experience as president of McKesson’s U.S. Pharmaceutical, Medical-Surgical and Specialty businesses provides a unique perspective on the challenges and opportunities facing our customers as healthcare reform drives further convergence throughout the industry.”

A 15-year McKesson veteran, Tyler has served as senior vice president of strategy and business development for McKesson Distribution Solutions, with responsibility for strategic planning, joint ventures, alliances and other business development activities for McKesson’s pharmaceutical distribution, medical-surgical, health solutions and retail automation groups. Following his role in strategy and business development, Tyler ran McKesson’s Specialty Care Solutions and Medical-Surgical businesses until assuming his most recent position as president of U.S. Pharmaceutical.

Tyler earned his Ph.D. and M.A. from the University of Chicago, Department of Economics in 1994, where he studied under a grant from the National Science Foundation, and earned his B.A. in economics with high honors from University of California Santa Cruz in 1989. He has served on the Board of Directors of Patterson Companies since 2009.

About McKesson

McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit http://www.mckesson.com.

Contacts

McKesson Corporation
Erin Lampert, 415-983-8391 (Investors)
Erin.lampert@McKesson.com
Kris Fortner, 415-983-8352 (Media)
Kris.fortner@McKesson.com

Contacts

McKesson Corporation
Erin Lampert, 415-983-8391 (Investors)
Erin.lampert@McKesson.com
Kris Fortner, 415-983-8352 (Media)
Kris.fortner@McKesson.com